Differential effects of α-helical and β-hairpin antimicrobial peptides against Acanthamoeba castellanii

Parasitology

Volumn 136, Issue 8, 2009, Pages 813-821

  Sacramento, R S ^a   Martins, R M ^a   Miranda, A ^a   Dobroff, A S S ^a   Daffre, S ^b   Foronda, A S ^b   De Freitas, D ^a   Schenkman, S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acanthamoeba castellanii; Amphipathic peptides permeabilization; Antimicrobial peptides; Protease

Indexed keywords

GOMESIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; UNCLASSIFIED DRUG;

ACANTHAMOEBA CASTELLANII; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CELL; ENZYME RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INCUBATION TIME; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRIATOMA INFESTANS;

ACANTHAMOEBA CASTELLANII; ACANTHAMOEBA KERATITIS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ARACHNIDA; CELL LINE; CELL MEMBRANE PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOCYTES; PROTEIN STRUCTURE, SECONDARY; RABBITS; SALIVARY PROTEINS AND PEPTIDES; SERINE PROTEINASE INHIBITORS; TRIATOMA; TROPHOZOITES;

ACANTHAMOEBA CASTELLANII; ACANTHOSCURRIA GOMESIANA; ARANEAE; HEXAPODA; ORYCTOLAGUS CUNICULUS; TRIATOMA INFESTANS;

EID: 67749109786     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182009006283     Document Type: Article

References (37)

1. Abedin, A., Mohammed, I., Hopkinson, A. and Dua, H. S. (2008). A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Investigative Ophthalmology & Visual Science 49, 28-33. doi:10.1167/iovs.07-0645.
2. Amino, R., Martins, R. M., Procopio, J., Hirata, I. Y., Juliano, M. A. and Schenkman, S. (2002). Trialysin, a novel pore-forming protein from saliva of hematophagous insects activated by limited proteolysis. Journal of Biological Chemistry 277, 6207-6213. doi:10.1074/jbc.M109874200. (Pubitemid 34968411)
3. Barbosa, F. M., Daffre, S., Maldonado, R. A., Miranda, A., Nimrichter, L. and Rodrigues, M. L. (2007). Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole. FEMS Microbiology Letters 274, 279-286. doi:10.1074/ jbc.M109874200. (Pubitemid 47256273)
4. Boman, H. G. (2003). Antibacterial peptides: basic facts and emerging concepts. Journal of Internal Medicine 254, 197-215. doi:10.1046/j.1365-2796. 2003.01228.x.
5. Borazjani, R. N., May, L. L., Noble, J. A., Avery, S. V. and Ahearn, D. G. (2000). Flow cytometry for determination of the efficacy of contact lens disinfecting solutions against Acanthamoeba spp. Applied and Environmental Microbiology 66, 1057-1061.
6. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Reviews. Microbiology 3, 238-250. doi:10.1038/ nrmicro1098.
7. Brown, K. L. and Hancock, R. E. (2006). Cationic host defense (antimicrobial) peptides. Current Opinion in Immunology 18, 24-30. doi:10.1016/j.coi.2005.11.004. (Pubitemid 43049644)
8. Bulet, P., Stocklin, R. and Menin, L. (2004). Anti-microbial peptides: from invertebrates to vertebrates. Immunological Reviews 198, 169-184. doi:10.1111/j.0105-2896.2004.0124.x.
9. Clarke, D. W. and Niederkorn, J. Y. (2006a). The immunobiology of Acanthamoeba keratitis. Microbes and Infection 8, 1400-1405. doi:10.1016/ j.micinf.2005.12.009.
10. Clarke, D. W. and Niederkorn, J. Y. (2006b). The pathophysiology of Acanthamoeba keratitis. Trends in Parasitology 22, 175-180. doi:10.1016/j.pt. 2006.02.004.
11. Dudley, R., Alsam, S. and Khan, N. A. (2008). The role of proteases in the differentiation of Acanthamoeba castellanii. FEMS Microbiology Letters 286, 9-15. doi:10.1111/j.1574-6968.2008.01249.x. (Pubitemid 352040389)
12. Fazio, M. A., Oliveira, V. X., Jr., Bulet, P., Miranda, M. T., Daffre, S. and Miranda, A. (2006). Structureactivity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Biopolymers 84, 205-218. doi:10.1002/bip.20396.
13. Feldman, S. T., Speaker, M. and Cleveland, P. (1991). Effect of magainins on Acanthamoeba castellanii. Review of Infectious Diseases 13 (Suppl 5), S439.
14. Gooi, P., Lee-Wing, M., Brownstein, S., El Defrawy, S., Jackson, W. B. and Mintsioulis, G. (2008). Acanthamoeba keratitis : persistent organisms without inflammation after 1 year of topical chlorhexidine. Cornea 27, 246-248. doi:10.1097/ ICO.0b013e31815b82a2. (Pubitemid 351158752)
15. Herz, N. L., Matoba, A. Y. and Wilhelmus, K. R. (2008). Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology 115, 866-869. doi:10.1016/ j.ophtha.2007.05.054.
16. Huang, L. C., Jean, D., Proske, R. J., Reins, R. Y. and McDermott, A. M. (2007). Ocular surface expression and in vitro activity of antimicrobial peptides. Current Eye Research 32, 595-609. doi:10.1080/ 02713680701446653. (Pubitemid 47400679)
17. John, T., Lin, J. and Sahm, D. F. (1990). Acanthamoeba keratitis successfully treated with prolonged propamidine isethionate and neomycin-polymyxingramicidin. Annals of Ophthalmology 22, 20-23.
18. Kashiwabuchi, R. T., de Freitas, D., Alvarenga, L. S., Vieira, L., Contarini, P., Sato, E., Foronda, A. and Hofling-Lima, A. L. (2008). Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis. Acta Ophthalmologica 86, 666-669. doi:10.1111/j.1600-0420.2007.01086.x.
19. Kim, W. T., Kong, H. H., Ha, Y. R., Hong, Y. C., Jeong, H. J., Yu, H. S. and Chung, D. I. (2006). Comparison of specific activity and cytopathic effects of purified 33 kDa serine proteinase from Acanthamoeba strains with different degree of virulence. Korean Journal of Parasitology 44, 321-330. doi:10.3347/ kjp.2006.44.4.321.
20. Kuhn-Nentwig, L. (2003). Antimicrobial and cytolytic peptides of venomous arthropods. Cellular and Molecular Life Sciences 60, 2651-2668. doi:10.1007/ s00018-003-3106-3108
21. Kulkarni, M. M., McMaster, W. R., Kamysz, E., Kamysz, W., Engman, D. M. and McGwire, B. S. (2006). The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Molecular Microbiology 62, 1484-1497. doi:10.1111/ j.1365-2958.2006. 05459.x. (Pubitemid 44707208)
22. Lee, J. E., Oum, B. S., Choi, H. Y., Yu, H. S. and Lee, J. S. (2007). Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea 26, 736-741. doi:10.1097/ ICO.0b013e31805b7e8e.
23. Mandard, N., Bulet, P., Caille, A., Daffre, S. and Vovelle, F. (2002). The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. European Journal of Biochemistry 269, 1190-1198. doi:10.1046/j.0014-2956.2002.02760.x. (Pubitemid 34175378)
24. Martins, R. M., Sforca, M. L., Amino, R., Juliano, M. A., Oyama, S., Jr., Juliano, L., Pertinhez, T. A., Spisni, A. and Schenkman, S. (2006). Lytic activity and structural differences of amphipathic peptides derived from trialysin. Biochemistry 45, 1765-1774. doi:10.1021/bi0514515. (Pubitemid 43222120)
25. Mattana, A., Biancu, G., Alberti, L., Accardo, A., Delogu, G., Fiori, P. L. and Cappuccinelli, P. (2004). In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii. Antimicrobial Agents and Chemoterapy 48, 4520-4527. doi:10.1128/AAC.48.12.4520- 4527.2004.
26. McIntosh, R. S., Cade, J. E., Al Abed, M., Shanmuganathan, V., Gupta, R., Bhan, A., Tighe, P. J. and Dua, H. S. (2005). The spectrum of antimicrobial peptide expression at the ocular surface. Investigative Ophthalmology & Visual Science 46, 1379-1385. doi:10.1167/iovs.04-0607. (Pubitemid 41685879)
27. Moreira, C. K., Rodrigues, F. G., Ghosh, A., Varotti, F. P., Miranda, A., Daffre, S., Jacobs-Lorena, M. and Moreira, L. A. (2007). Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Experimental Parasitology 116, 346-353. doi:10.1016/j.exppara.2007.01.022. (Pubitemid 46856416)
28. Na, B. K., Cho, J. H., Song, C. Y. and Kim, T. S. (2002). Degradation of immunoglobulins, protease inhibitors and interleukin-1 by a secretory proteinase of Acanthamoeba castellanii. Korean Journal of Parasitology 40, 93-99. doi:10.3347/kjp.2002.40.2.93
29. Neff, R. J. (1957). Purification, axenic cultivation, and description of a soil amoeba, Acanthamoeba sp. Journal of Protozoology 4, 176-182. doi:10.1111/j.1550- 7408.1957.tb.02505.x
30. Niederkorn, J. Y., Ubelaker, J. E., McCulley, J. P., Stewart, G. L., Meyer, D. R., Mellon, J. A., Silvany, R. E., He, Y. G., Pidherney, M., Martin, J. H. and Alizadeh, H. (1992). Susceptibility of corneas from various animal species to in vitro binding and invasion by Acanthamoeba castellanii. Investigative Ophthalmology & Visual Science 33, 104-112.
31. Ondarza, R. N. (2007). Drug targets from human pathogenic amoebas: Entamoeba histolytica, Acanthamoeba polyphaga and Naegleria fowleri. Infectious Disorders Drug Targets 7, 266-280. doi:10.2124/187152607782110059
32. Perez-Santonja, J. J., Kilvington, S., Hughes, R., Tufail, A., Matheson, M. and Dart, J. K. (2003). Persistently culture positive acanthamoeba keratitis : in vivo resistance and in vitro sensitivity. Ophthalmology 110, 1593-1600. doi:10.1016/S0161-6420(03)00481-0. (Pubitemid 36962496)
33. Schuster, F. L. and Jacob, L. S. (1992). Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga. Antimicrobial Agents and Chemoterapy 36, 1263-1271.
34. Silva, P. I., Jr., Daffre, S. and Bulet, P. (2000). Isolation and characterization of gomesin, an 18-residue cysteinerich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. Journal of Biological Chemistry 275, 33464-33470. (Pubitemid 30808558)
35. Sissons, J., Alsam, S., Goldsworthy, G., Lightfoot, M., Jarroll, E. L. and Khan, N. A. (2006). Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis. BMC Microbiology 6, 42. doi:10.1186/ 1471-2180-6-42. (Pubitemid 43764074)
36. Taylor, W. M., Pidherney, M. S., Alizadeh, H. and Niederkorn, J. Y. (1995). In vitro characterization of Acanthamoeba castellanii cytopathic effect. Journal of Parasitology 81, 603-609.
37. Xuguang, S., Yanchuang, L., Feng, Z., Shiyun, L. and Xiaotang, Y. (2006). Pharmacokinetics of chlorhexidine gluconate 0.02% in the rabbit cornea. Journal of Ocular Pharmacology and Therapeutics 22, 227-230. doi:10.1089/ jop.2006.22.227 (Pubitemid 44689661)